CD24 and hepatocellular carcinoma: For example, high expression of CD24 is correlated with tumor progression and metastasis in hepatocellular carcinoma and bladder cancer, and blocking its activity by ɑ-CD24 antibodies in mouse models reduced tumorigenesis [10].